Anastrozole is to be funded in the UK for use as a preventive treatment for breast cancer after becoming the first product to be repurposed via a multi-agency program that was set up in 2021 to look at using existing medicines in new ways.
It is hoped that the move could help prevent around 2,000 cases of breast cancer in England.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?